THE UNIVERSITY HOSPITAL OF ARKANSAS

PHARMACY DEPARTMENT

GUIDELINES FOR USE

The "GUIDELINES FOR USE" have been developed through a collaborative effort of members of the medical and surgical specialties and the pharmacy department. Each set of "GUIDELINES FOR USE" has been subjected to a final review and approval process by the Pharmacy Committee before publication.

The purpose of the "GUIDELINES FOR USE" is to establish a standard for drug monitoring (DUR, DUE, etc). Drug monitoring is a requirement of the Joint Commission on Accreditation of Healthcare Organizations (JCAHO).

Subsequent use of the "GUIDELINES FOR USE" during the monitoring process are further subjected to peer evaluation of drug therapies and the specific circumstances and patient needs. Drug monitoring results are used for informational and training purposes. The identity of the provider of care and the patient are held in strict confidence.

ALBUMIN

ALCOHOL WITHDRAWAL AND DELIRIUM TREMENS

ALTEPLASE FOR CATHETERS

AMINOGLYCOSIDES - Amikacin

AMINOGLYCOSIDES - Gentamicin-Tobramycin

AMPHOTERICIN B

AMPHOTERICIN B LIPID FORMULATION

AMPICILLIN-SULBACTAM

AZITHROMYCIN

AZTREONAM

CEFOTAXIME

CEFAZOLIN

SECOND GENERATION CEPHALOSPORINS

SECOND GENERATION ORAL CEPHALOSPORINS

CEFTAZIDIME

CEFTRIAXONE

C. Difficile Colitis - Treatment

COX-2 INHIBITORS

DEXMEDETOMIDINE

EPOGEN

FLUCONAZOLE

FOSPHENYTOIN

GANCICLOVIR

HALOPERIDOL

H-2 ANTAGONISTS

HETASTARCH

IMIPENEM-CILASTIN

Intravenous Sedatives and Narcotics

KETOROLAC

MISOPROSTOL

MORPHINE LIPOSOMAL (DEPODUR)

NEUROMUSCULAR BLOCKERS

PEGFILGASTRIM

GUIDELINES FOR IV POTASSIUM THERAPY

PROPHYLACTIC USE OF ANTIBIOTICS

QUINOLONE

SALMETEROL

VANCOMYCIN

ZOLENDRONATE